vs
NOVAVAX INC（NVAX）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
NOVAVAX INC的季度营收约是REPUBLIC BANCORP INC的1.6倍（$147.3M vs $94.3M），REPUBLIC BANCORP INC净利率更高（24.2% vs 11.9%，领先12.3%），NOVAVAX INC同比增速更快（66.8% vs 5.3%），REPUBLIC BANCORP INC自由现金流更多（$161.1M vs $-41.6M），过去两年NOVAVAX INC的营收复合增速更高（25.3% vs -11.5%）
诺瓦瓦克斯是一家总部位于美国马里兰州盖瑟斯堡的生物科技企业，专注于传染病疫苗研发。其开发的新冠疫苗现由赛诺菲负责商业化，同时还在布局流感、呼吸道合胞病毒（RSV）、禽流感、带状疱疹、艰难梭菌感染、疟疾等多个领域的疫苗管线。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
NVAX vs RBCAA — 直观对比
营收规模更大
NVAX
是对方的1.6倍
$94.3M
营收增速更快
NVAX
高出61.5%
5.3%
净利率更高
RBCAA
高出12.3%
11.9%
自由现金流更多
RBCAA
多$202.7M
$-41.6M
两年增速更快
NVAX
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $147.3M | $94.3M |
| 净利润 | $17.5M | $22.8M |
| 毛利率 | 85.0% | — |
| 营业利润率 | 9.7% | 29.3% |
| 净利率 | 11.9% | 24.2% |
| 营收同比 | 66.8% | 5.3% |
| 净利润同比 | 121.6% | 20.0% |
| 每股收益（稀释后） | $0.28 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVAXRBCAA
| Q4 25 | $147.3M | $94.3M | ||
| Q3 25 | $70.4M | $93.5M | ||
| Q2 25 | $239.2M | $93.8M | ||
| Q1 25 | $666.5M | $135.8M | ||
| Q4 24 | $88.3M | $89.5M | ||
| Q3 24 | $84.5M | $88.1M | ||
| Q2 24 | $415.5M | $86.9M | ||
| Q1 24 | $93.9M | $120.3M |
净利润NVAXRBCAA
| Q4 25 | $17.5M | $22.8M | ||
| Q3 25 | $-202.4M | $29.7M | ||
| Q2 25 | $106.5M | $31.5M | ||
| Q1 25 | $518.6M | $47.3M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | $-121.3M | $26.5M | ||
| Q2 24 | $162.4M | $25.2M | ||
| Q1 24 | $-147.6M | $30.6M |
毛利率NVAXRBCAA
| Q4 25 | 85.0% | — | ||
| Q3 25 | 69.5% | — | ||
| Q2 25 | 93.6% | — | ||
| Q1 25 | 97.9% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 28.3% | — | ||
| Q2 24 | 88.9% | — | ||
| Q1 24 | 36.9% | — |
营业利润率NVAXRBCAA
| Q4 25 | 9.7% | 29.3% | ||
| Q3 25 | -252.7% | 40.4% | ||
| Q2 25 | 42.2% | 43.0% | ||
| Q1 25 | 77.4% | 44.1% | ||
| Q4 24 | — | 25.8% | ||
| Q3 24 | -158.6% | 38.4% | ||
| Q2 24 | 38.7% | 37.0% | ||
| Q1 24 | -154.3% | 32.2% |
净利率NVAXRBCAA
| Q4 25 | 11.9% | 24.2% | ||
| Q3 25 | -287.3% | 31.8% | ||
| Q2 25 | 44.5% | 33.5% | ||
| Q1 25 | 77.8% | 34.8% | ||
| Q4 24 | — | 21.2% | ||
| Q3 24 | -143.5% | 30.1% | ||
| Q2 24 | 39.1% | 29.0% | ||
| Q1 24 | -157.2% | 25.4% |
每股收益（稀释后）NVAXRBCAA
| Q4 25 | $0.28 | — | ||
| Q3 25 | $-1.25 | — | ||
| Q2 25 | $0.62 | — | ||
| Q1 25 | $2.93 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.76 | — | ||
| Q2 24 | $0.99 | — | ||
| Q1 24 | $-1.05 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $735.1M | $220.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-127.8M | $1.1B |
| 总资产 | $1.2B | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NVAXRBCAA
| Q4 25 | $735.1M | $220.0M | ||
| Q3 25 | $762.9M | $484.2M | ||
| Q2 25 | $612.3M | $484.8M | ||
| Q1 25 | $731.5M | $793.0M | ||
| Q4 24 | $923.1M | $432.2M | ||
| Q3 24 | $909.5M | $530.9M | ||
| Q2 24 | $1.0B | $400.1M | ||
| Q1 24 | $480.6M | $546.4M |
股东权益NVAXRBCAA
| Q4 25 | $-127.8M | $1.1B | ||
| Q3 25 | $-156.7M | $1.1B | ||
| Q2 25 | $37.6M | $1.1B | ||
| Q1 25 | $-75.6M | $1.0B | ||
| Q4 24 | $-623.8M | $992.0M | ||
| Q3 24 | $-526.4M | $979.7M | ||
| Q2 24 | $-431.7M | $955.4M | ||
| Q1 24 | $-867.1M | $935.6M |
总资产NVAXRBCAA
| Q4 25 | $1.2B | $7.0B | ||
| Q3 25 | $1.2B | $7.0B | ||
| Q2 25 | $1.3B | $7.0B | ||
| Q1 25 | $1.3B | $7.1B | ||
| Q4 24 | $1.6B | $6.8B | ||
| Q3 24 | $1.7B | $6.7B | ||
| Q2 24 | $1.8B | $6.6B | ||
| Q1 24 | $1.4B | $6.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-39.5M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | $-41.6M | $161.1M |
| 自由现金流率自由现金流/营收 | -28.2% | 170.9% |
| 资本支出强度资本支出/营收 | 1.4% | 7.5% |
| 现金转化率经营现金流/净利润 | -2.25× | 7.37× |
| 过去12个月自由现金流最近4个季度 | $-250.2M | $288.6M |
8季度趋势，按日历期对齐
经营现金流NVAXRBCAA
| Q4 25 | $-39.5M | $168.2M | ||
| Q3 25 | $107.8M | $33.3M | ||
| Q2 25 | $-127.5M | $8.4M | ||
| Q1 25 | $-185.5M | $93.2M | ||
| Q4 24 | $-87.3M | $149.0M | ||
| Q3 24 | $-144.8M | $51.3M | ||
| Q2 24 | $314.3M | $4.0M | ||
| Q1 24 | $-83.6M | $71.2M |
自由现金流NVAXRBCAA
| Q4 25 | $-41.6M | $161.1M | ||
| Q3 25 | $105.8M | $30.8M | ||
| Q2 25 | $-127.7M | $5.2M | ||
| Q1 25 | $-186.7M | $91.6M | ||
| Q4 24 | $-100.3M | $143.2M | ||
| Q3 24 | $-146.2M | $49.8M | ||
| Q2 24 | $311.4M | $2.7M | ||
| Q1 24 | $-90.4M | $69.1M |
自由现金流率NVAXRBCAA
| Q4 25 | -28.2% | 170.9% | ||
| Q3 25 | 150.2% | 32.9% | ||
| Q2 25 | -53.4% | 5.5% | ||
| Q1 25 | -28.0% | 67.4% | ||
| Q4 24 | -113.6% | 160.0% | ||
| Q3 24 | -173.0% | 56.5% | ||
| Q2 24 | 74.9% | 3.1% | ||
| Q1 24 | -96.4% | 57.5% |
资本支出强度NVAXRBCAA
| Q4 25 | 1.4% | 7.5% | ||
| Q3 25 | 2.9% | 2.6% | ||
| Q2 25 | 0.1% | 3.5% | ||
| Q1 25 | 0.2% | 1.2% | ||
| Q4 24 | 14.8% | 6.5% | ||
| Q3 24 | 1.6% | 1.7% | ||
| Q2 24 | 0.7% | 1.5% | ||
| Q1 24 | 7.3% | 1.7% |
现金转化率NVAXRBCAA
| Q4 25 | -2.25× | 7.37× | ||
| Q3 25 | — | 1.12× | ||
| Q2 25 | -1.20× | 0.27× | ||
| Q1 25 | -0.36× | 1.97× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | 1.94× | 0.16× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NVAX
| Licensing Royalties And Other | $107.9M | 73% |
| Products | $39.2M | 27% |
RBCAA
暂无分部数据
